![]() |
| Home | Press releases | News | Resources | Contact Us | H·E·A·R·T UK |
|
|
|
Thousands of people in England are unaware that they are at risk of developing heart disease due to an undiagnosed genetic condition, says the Royal College of Physicians Jun 26, 2009Familial hypercholesterolaemia (FH) is an inherited condition causing high levels of LDL cholesterol, and increased risk of coronary heart disease in men in their 50s and women in their 60s. Early treatment with statins has been shown to reduce risk and improve life expectancy to normal. A pilot audit of 248 cases in 12 hospitals in England and two in Wales, funded by the Department of Health and the Welsh Assembly Government and carried out by the Clinical Effectiveness and Evaluation Unit at the Royal College of Physicians, found that while care for identified patients was generally good, very few families were being systematically genetically screened, and there were not enough facilities for diagnosing and treating children with FH in the right care settings. The audit standards were based on the NICE clinical guidelines for the diagnosis and management of FH published in 2008. An estimated 120,000 people in England have the condition, as many as have Type I diabetes, and 85% of cases are currently undiagnosed. Improving resources for treatment and screening will not only save many lives, but will save the NHS vital resources in future. The audit report makes several key recommendations:
• NHS Trusts will need additional resources to find the undiagnosed cases, in particular more specialist doctors and nurses, and funding to pay for DNA diagnosis
Professor Steve Humphries, FH Audit Project Director and Director of the Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, London, said:
Professor Roger Boyle, National Clinical Director for Heart Disease and Stroke said,
Dr. Alan Rees, Chairman of HEART UK - The Cholesterol Charity - said: “We fail to diagnose 80% of people with FH in the UK. What clearly hasn’t been happening is the testing of every family member of someone with FH which is essential. What we need is an integrated national approach to this problem. HEART UK has the answer - it’s a tool kit that every commissioning authority should use. This will prevent premature heart attacks and save lives.” Dr Mike Knapton, Associate Medical Director at the British Heart Foundation said: “Funding should be made available as a matter of urgency so we can test the family members of people with FH. There are around 100,000 people going about their lives unaware they are at risk of this silent killer - people who, with the right treatment and management could have a normal life expectancy. The longer the health service delays making this vital investment lives will continue to be needlessly cut short.”
Other news coverage includes:
|